282 related articles for article (PubMed ID: 18362471)
61. Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience.
Hoem D; Viste A
Eur J Surg Oncol; 2012 Mar; 38(3):245-51. PubMed ID: 22217907
[TBL] [Abstract][Full Text] [Related]
62. Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?
Yamada S; Nakao A; Fujii T; Sugimoto H; Kanazumi N; Nomoto S; Kodera Y; Takeda S
Pancreas; 2009 Jan; 38(1):e13-7. PubMed ID: 18797422
[TBL] [Abstract][Full Text] [Related]
63. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.
Schmidt CM; Glant J; Winter JM; Kennard J; Dixon J; Zhao Q; Howard TJ; Madura JA; Nakeeb A; Pitt HA; Cameron JL; Yeo CJ; Lillemoe KD
Surgery; 2007 Oct; 142(4):572-8; discussion 578-80. PubMed ID: 17950350
[TBL] [Abstract][Full Text] [Related]
64. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
65. Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes.
Martin RC; Scoggins CR; Egnatashvili V; Staley CA; McMasters KM; Kooby DA
Arch Surg; 2009 Feb; 144(2):154-9. PubMed ID: 19221327
[TBL] [Abstract][Full Text] [Related]
66. [Surgical resection of pancreatic adenocarcinoma: indications and contraindications, pronostic factors and survival, recent advances].
Delpero JR
Cancer Radiother; 2004 Nov; 8 Suppl 1():S73-9. PubMed ID: 15679251
[TBL] [Abstract][Full Text] [Related]
67. Clinical results of extended lymphadenectomy and intraoperative radiotherapy for pancreatic adenocarcinoma.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Tanizawa Y
Hepatogastroenterology; 2007 Mar; 54(74):564-9. PubMed ID: 17523323
[TBL] [Abstract][Full Text] [Related]
68. Outcome of distal pancreatectomy for pancreatic adenocarcinoma.
Goh BK; Tan YM; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
Dig Surg; 2008; 25(1):32-8. PubMed ID: 18292659
[TBL] [Abstract][Full Text] [Related]
69. Analysis of long-term survivors after surgical resection for pancreatic cancer.
Han SS; Jang JY; Kim SW; Kim WH; Lee KU; Park YH
Pancreas; 2006 Apr; 32(3):271-5. PubMed ID: 16628082
[TBL] [Abstract][Full Text] [Related]
70. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
71. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
72. The impact of obesity on outcomes following pancreatectomy for malignancy.
Benns M; Woodall C; Scoggins C; McMasters K; Martin R
Ann Surg Oncol; 2009 Sep; 16(9):2565-9. PubMed ID: 19557479
[TBL] [Abstract][Full Text] [Related]
73. Re-resection for isolated local recurrence of pancreatic cancer is feasible, safe, and associated with encouraging survival.
Strobel O; Hartwig W; Hackert T; Hinz U; Berens V; Grenacher L; Bergmann F; Debus J; Jäger D; Büchler M; Werner J
Ann Surg Oncol; 2013 Mar; 20(3):964-72. PubMed ID: 23233235
[TBL] [Abstract][Full Text] [Related]
74. Survival benefit of pancreaticoduodenectomy in a Japanese fashion for a limited group of patients with pancreatic head cancer.
Takao S; Shinchi H; Maemura K; Kurahara H; Natsugoe S; Aikou T
Hepatogastroenterology; 2008; 55(86-87):1789-95. PubMed ID: 19102395
[TBL] [Abstract][Full Text] [Related]
75. Laparoscopic pancreaticoduodenectomy: technique and outcomes.
Palanivelu C; Jani K; Senthilnathan P; Parthasarathi R; Rajapandian S; Madhankumar MV
J Am Coll Surg; 2007 Aug; 205(2):222-30. PubMed ID: 17660068
[TBL] [Abstract][Full Text] [Related]
76. Expression of cytokeratin-20 in pancreatic cancer: an indicator of poor outcome after R0 resection.
Schmitz-Winnenthal FH; Volk C; Helmke B; Berger S; Hinz U; Koch M; Weitz J; Kleeff J; Friess H; Zöller M; Büchler MW; Z'graggen K
Surgery; 2006 Jan; 139(1):104-8. PubMed ID: 16364723
[TBL] [Abstract][Full Text] [Related]
77. Postresection survival outcomes of pancreatic cancer according to demographic factors and socio-economic status.
Kuhn Y; Koscielny A; Glowka T; Hirner A; Kalff JC; Standop J
Eur J Surg Oncol; 2010 May; 36(5):496-500. PubMed ID: 19748206
[TBL] [Abstract][Full Text] [Related]
78. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
79. Portal or superior mesenteric vein resection for pancreatic head adenocarcinoma: prognostic value of the length of venous resection.
Kaneoka Y; Yamaguchi A; Isogai M
Surgery; 2009 Apr; 145(4):417-25. PubMed ID: 19303991
[TBL] [Abstract][Full Text] [Related]
80. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
